Gabriel Morán

In vitro bioassay to detect reaginic antibodies from the serum of horses affected with Recurrent Airway Obstruction

In horses, Recurrent Airway Obstruction (RAO) is an allergic disease that involves IgE mediated Type I Hypersensitivity responses. The development of this type of allergy involves a series of events that begins with reaginic antibodies, mainly IgE and some IgG subclasses. These reaginic antibodies bind with high affinity, via the Fc portion, to FcεRI receptors on the membrane of mast cells and basophils. Once bound, environmental allergens cross-link the antibodies, which results in mast cell degranulation leading to the production of histamine and other chemical mediators that act together to induce airway inflammation. RAO-affected horses present with coughing, respiratory distress, airway obstruction and poor performance. The aspect of the RAO has been extensively studied, yet the precise sequence of events is still not well understood. Therefore, this study proposes a bioassay for reaginic antibody detection from horse serum of RAO-affected individuals, in order to determine the etiology of disease, which mediate immediate type reactions. The technique involves measuring in vitro calcium mobilization in RBL-2H3 cells following incubation with horse serum from affected or unaffected horses and one of the RAO antigens (Aspergillus fumigatus). The results presented here demonstrate that 30% of RAO-affected horses react positively in this in vitro bioassay, whereas unaffected horses do not. This bioassay may facilitate further research on RAO and other allergic diseases in horses.

Detection of reaginic antibodies against Faenia rectivirgula from the serum of horses affected with Recurrent Airway Obstruction by an in vitro bioassay.

Reaginic antibodies, mainly of the IgE and some IgG subclasses, play an important role in the induction of type I immediate hypersensitivity reactions. These antibodies bind through their Fc fragment to high affinity receptors (FcεRI) present in the membrane of mast cells and basophils. Previously, several studies have investigated the role of reaginic antibodies in the pathogenesis of RAO. However, whereas immunological aspects of RAO have been extensively studied, the precise sequence of events is still not well understood and role of IgE in this disease still remains controversial. Therefore, in this study a bioassay was developed for reaginic antibody determination in serum from RAO-affected horses in order to determine the etiology of disease. The technique involves measuring in vitro calcium mobilization in RBL-2H3 cells following incubation with horse serum from RAO-affected or unaffected horses and one of the RAO antigens (Faenia rectivirgula). Results demonstrated that 15% of samples from the RAO-affected horses reacted positively in this in vitro bioassay, whereas the samples from unaffected horses did not. This bioassay indicates that reaginic antibodies could be involved in the immunological mechanism leading to RAO; and this technique may facilitate future research in other allergic diseases in horses.

Tamoxifen as a new therapeutic tool for neutrophilic lung inflammation.

Neutrophilic asthma is an important disease subgroup, including patients with severe phenotypes and erratic responses to standard treatments. Tamoxifen (TX), a selective estrogen receptor modulator (SERM) used as treatment of human breast cancer, has been shown to induce early apoptosis of equine blood and bronchoalveolar lavage fluid (BALF) neutrophils in vitro. Equine recurrent airway obstruction (RAO) is a naturally occurring neutrophilic condition, closely related with human asthma. Our purpose was to investigate the therapeutic potential of tamoxifen in horses with neutrophilic lung inflammation.

Apoptotic effects of tamoxifen on leukocytes from horse peripheral blood and bronchoalveolar lavage fluid

A reduction in inflammatory cell apoptosis is an important concept in the maintenance of inflammation and a potential target for the resolution of inflammation in many inflammatory diseases. Dysregulation of apoptosis has been implicated in a range of diseases, including tumors, neurodegenerative disorders and autoimmunity, and may also be implicated in allergic asthma. In horses, recurrent airway obstruction (RAO) is an asthma-like condition that is characterized increased survival neutrophil bronchial. Tamoxifen is a synthetic, non-steroidal, anti-estrogen agent that is widely used for treating all stages of breast cancer and has been approved for the prevention of breast cancer in high-risk women. The observed efficacy of tamoxifen has been attributed to both growth arrest and the induction of apoptosis. Therefore, the aim of our study was to evaluate the ability of tamoxifen to induce apoptosis in vitro in granulocytic cells from peripheral blood and in mononuclear cells from bronchoalveolar lavage fluid (BALF) in horses. Flow cytometry using commercial AnnexinV-FITC and propidium iodide was used to quantify early and late apoptotic leukocytes, respectively. The results showed a significant increase in early apoptosis in peripheral blood and bronchial granulocytic cells treated with tamoxifen. The rate of early apoptosis of mononuclear cells from blood and BALF when incubated with tamoxifen was significantly lower compared with granulocytic cells. We did not observe a direct effect of tamoxifen on late apoptosis in any of the in vitro assays in the cell types used here. These results indicate that the apoptotic mechanisms under these experimental conditions would affect only blood and BALF granulocytic cells, particularly in early apoptosis. Finally, further in vitro and in vivo studies are needed to better understand apoptotic mechanisms because tamoxifen could be used to treat chronic, inflammatory pathologies associated with granulocytes and allergic diseases, such as asthma or equine RAO.

Características citológicas del lavado bronqueoalveolar y respuesta inmune humoral frente a Aspergillus fumigatus en caballos Chilotes con obstrucción recurrente de las vías aéreas

SUMMARY In this study, the presence and characteristics of the recurrent airway obstruction (RAO), in Chilote horses were investigated. The Chilote horse is a breed of small and very rustic horses, descendent from the horses that were brought by the spaniards during the colony and remained isolated in the Chiloe island, south of Chile, for a long time. Twenty two animals, all from the same farm and living under similar conditions, were physically examined. In all cases broncheoalveolar lavage (BALF) was performed and the recovered resident cells from the respiratory tract were studied in smears stained with May Grewald – Giemsa; the level of antibodies against Aspergillus fumigatus was determined by ELISA. The results indicate that out of the total population of animals under investigation, 13 showed clinical signs compatible with RAO and 9 were normal. In all cases, the animals that were considered RAO positive showed a higher percentage of polymorphonuclear neutrophils in the BALF: furthermore, a clear positive correlation between the relative amount of neutrophilic cells present in the airways and the severity of the signs observed during the physical examination exists. All of the animals, healthy and RAO positive horses, showed high titres of antibodies against A. fumigatus, a well known allergen, commonly distributed in the region and present in the hay/straw. Our results show that Chilote horses, even though they are a rustic bread, are very susceptible to become RAO positive with similar characteristics to those described in other breeds, moreover, all animals were sensitized to A. fumigatus antigens showing the immunogenicity and the important distribution of this fungal allergen.

Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction

Recurrent airway obstruction (RAO, also known as equine heaves) is an inflammatory condition similar to human asthma caused by exposure of susceptible horses to poorly ventilated stable environments. The disease is characterized by neutrophilic airway inflammation, mucus hypersecretion and reversible bronchoconstriction. This inflammatory process is mediated by several factors, including antibodies, cytokines, resident cells of the airway and inflammatory cellular components that arrive in the respiratory tract. An increasing body of evidence has lent support to the concept that a dysregulation of T cell apoptosis may play a central role in the development of airway inflammation and the associated asthma. Therefore, the aim of this study was to investigate early and late apoptosis of CD4 and CD8 T cell subpopulations obtained from the airways of acute RAO-positive animals after exposure to hay/straw. The percentages of CD4 and CD8 T cells and their associated frequencies of apoptosis were quantified using flow cytometry. Hay/straw exposure induced clinical airway obstruction, airway neutrophilia and increased airway mucus production in RAO-positive horses. In addition, allergen exposure increased the percentage of CD4 T cells in RAO-positive horses as well as the frequency of early and late apoptosis in both CD4 and CD8 lymphocyte subpopulations. These results suggest that the higher frequency of lymphocyte apoptosis may play a role in disease progression of horses afflicted with RAO and may partially explain the characteristic remission of this pathological condition once the allergen source is removed. However, further studies are needed to clarify the role of T cell apoptosis in RAO-affected horses.

Reaginic antibodies from horses with Recurrent Airway Obstruction produce mast cell stimulation

Reaginic antibodies (IgE and some IgG subclasses) and mast cells play important roles in the induction of type I immediate hypersensitivity reactions. These antibodies bind through their Fc fragment to high affinity receptors (FcεRI) present in the membrane of mast cells and basophils. The cross-linking of the receptor initiates a coordinated sequence of biochemical and morphological events that results in exocytosis of secretory granules containing pre-formed inflammatory mediators, secretion of newly formed lipid mediators, and secretion of cytokines. Previously, several studies have investigated the role of reaginic antibodies in the pathogenesis of Recurrent Airway Obstruction (RAO). However, whereas the immunological aspects of RAO have been extensively studied, the precise sequence of events involved in the pathogenesis remains not completely understood, and the role of IgE in this disease remains controversial. Therefore, in this study, several bioassays were conducted to determine whether reaginic antibodies from RAO-affected horses have the ability to activate mast cells. These bioassays involved measuring degranulation of rat peritoneal mast cells, activation of NF-κB and morphological changes in basophilic leukemia cells (RBL-2H3) following incubation with horse serum from RAO-affected horses that were sensitive and insensitive to Aspergillus fumigatus (A. fumigatus) or from unaffected horses. Our results show that reaginic antibodies from horses sensitive to A. fumigatus were able to degranulate rat peritoneal mast cells. In additon, there was an increase in the activity of the transcription factor NF-κB in RBL-2H3 cells, and morphological changes were observed in these cells once cross-linking was produced. These findings were not found in horses not sensitive to A. fumigatus and healthy horses. These bioassays demonstrate the ability of reaginic antibodies to stimulate mast cells and indicate that these antibodies could be involved in the immunological mechanisms leading to RAO.

Obstrucción recurrente de las vías aéreas en el caballo

SUMMARY Recurrent airway obstruction (RAO) is an inflammatory process caused by hypersensitivity due to inhalation of alergen agents, the process is characterized by inflammation of airways, mucus hypersecretion and obstruction. The onset of the disease is triggered by the surrounding where horses are stabled; often abundant organic dust of the hay, straw of bed, dust of the atmosphere, microorganisms contained in airway of the animals and the material of construction of the stable are important predisponent causes of RAO. The symtoms are due to airways inflammation caused by an type I hipersensitivity reaction in first moment, with the consecuent release of histamine and other pro-imflamatory agents, followed by a hipersensitivity reaction type III based on immune complex formation in situ with complement activation, and production of chemioatractants for neutrophils. This imflamatory process induces in other resident cells the activation of many genes using the NF-kB as common trancripcional factor. The diagnosis method for this alergic process is the broncheoalveolar lavage (BAL) followed by cytologic examination. In the case of RAO positive horses, the citology of BAL is characterized by a significant increase of neutrophils and in smaller percentage of eosinophils and mast cells. Administration of glucocorticoids sytemically or by inhalation, reduces the inflammation and obstruction of airways. The bronchodilators drugs also can be used to alleviate respiratory distress. The present work reviews the associated factors involved, the predisponent, the inmmunologic and molecular mechanisms associate to the disease, as well as diagnosis and treatment.

Participation of T regulatory cells in equine recurrent airway obstruction.

Recurrent airway obstruction (RAO) is an equine immune-mediated disease with a high incidence worldwide. The aim of this work was to contribute to the understanding of RAO pathogenesis by studying T cells bearing regulatory markers in peripheral blood (PB) and in bronchoalveolar lavage fluid (BALF) recovered from the same group of susceptible horses before and after exposure to moldy hay, which has been shown to induce RAO signology in our horse herd. With this purpose, mononuclear cells were obtained from the BALF and PB from horses before and after antigenic challenge and were stained with fluorochrome-conjugated antibodies against CD4, CD25 and Foxp3 and subsequently analyzed by flow cytometry. The results indicated that the percentage of CD4+, Foxp3+ cells clearly increased in PB and BALF obtained from horses with RAO. In addition, the percentage of CD4+, CD25(high) cells was greatly augmented in BALF of RAO positive horses compared with a baseline. No changes were observed in the PB compartment. The percentage of CD4+, CD25(high), Foxp3+ cells in BALF increased in horses with active disease compared to horses in remission; this cell population also does not show changes in the PB compartment when RAO positive and RAO negative horses were compared. On the other hand, when the percentage of CD4, Foxp3 positive cells were compared with the percentage of CD4+, CD25(high) cells, the numbers were very similar. This observation was true for PB and BALF cells from non exposed horses as well as horses exposed to antigen. In all the experimental situations studied, the population expressing all of the markers CD4+, CD25(high), Foxp3+ represent only a minor percentage of CD4+, CD25(high) or CD4+, Foxp3 subpopulations; therefore, an significant number of CD4+, CD25(high), Foxp3- and CD4+, CD25(null), Foxp3+ cells must exist. Finally, we conclude that horses with RAO show an airway accumulation of T cells bearing regulatory markers that probably are modulating the course of this disease, and that these T cells may be involved in the resolution of immune-mediated bronchial inflammation.

Inhalation of Aspergillus fumigatus spores induces airway inflammation in mice in a similar manner as observed in Recurrent Airway Obstruction in horses

El objetivo de este estudio fue determinar si ratones expuestos a esporas de Aspergillus fumigatus desarrollan una inflamacion alergica de las vias respiratorias similar a la observada en equinos con Obstruccion Recurrente de las Vias Aereas (ORVA). Para esto se utilizaron ratones Rockefeller (RK) de 2, 5, 6 y 8 meses respectivamente, los cuales se mantuvieron por 16 dias en jaulas que contenian heno contaminado con A. fumigatus. Posterior a la exposicion, los animales fueron sangrados y sacrificados para la obtencion de suero sanguineo, lavado broncoalveolar (LBA) y muestras de tejido pulmonar. Ademas, se midieron los niveles de anticuerpos especificos para A. fumigatus a traves de un ELISA indirecto. Los resultados mostraron que la inhalacion de esporas de A. fumigatus en ratones induce una respuesta alergica inflamatoria en pulmones similar a lo observado en ORVA equino, con un aumento del porcentaje de neutrofilos en el LBA y cambios histologicos pulmonares caracteristicos de una hipersensibilidad bronquial. Asimismo, se observo un aumento de los niveles de inmunoglubulinas IgE, IgG1 e IgG2a especificas para este hongo en fluidos bronquiales. Ademas, los animales remitieron el estres respiratorio cuando fueron expuestos en un ambiente de remision. Se puede concluir que la simple exposicion de esporas de A. fumugatus produce una condicion alergica similar al ORVA en equinos. Por lo tanto, este modelo experimental puede ser de utilidad para el estudio de los mecanismos inmunologicos, y probar nuevas opciones terapeuticas para esta enfermedad respiratoria de los caballos.